News & Updates
Filter by Specialty:
Tofacitinib on par with TNFi in rheumatoid arthritis
Tofacitinib demonstrates similar physician- and patient-reported effectiveness to tumour necrosis factor inhibitors (TNFi) in rheumatoid arthritis (RA), according to a study.
Tofacitinib on par with TNFi in rheumatoid arthritis
19 May 2022
Musculoskeletal pain common in T2D but does not influence treatment goals
Musculoskeletal pain is a common coexisting symptom in patients with type 2 diabetes (T2D), with most patients having knee or lower back pain, a study reports. However, despite the major disability burden associated with these types of pain, it does not seem to get in the way of achieving treatment targets.
Musculoskeletal pain common in T2D but does not influence treatment goals
10 May 2022
Intensive urate lowering of little benefit to patients with erosive gout
A more intensive serum urate-lowering therapy falls short of improving bone erosion scores in patients with erosive gout, in addition to being associated with a high treatment burden, as shown in a study.
Intensive urate lowering of little benefit to patients with erosive gout
27 Apr 2022
US-guided corticosteroid injection relieves symptoms in hip OA
An ultrasound (US)-guided intra-articular hip injection of corticosteroid and local anaesthetic, administered with advice and education, results in a rapid and sustained symptom response for individuals with hip osteoarthritis (OA), a study has shown.
US-guided corticosteroid injection relieves symptoms in hip OA
20 Apr 2022
BMI mediates pain severity in hands, lower extremities in patients with hand OA
In patients with hand osteoarthritis (OA), the higher the body mass index (BMI), the more severe the pain in the hands, feet, and knees/hips is, according to a study. The generalized pain experienced by overweight or obese OA patients may be attributed to low-grade inflammation.